Research location
Carina Heights
Queensland, Australia
Advertisement
Research activity in Carina Heights
Queensland, AustraliaCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Carina Heights
9 linked trials · page 1 of 1A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02164513 · 2014-06-30 · 1 site observation
COMPLETED
Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 DiabetesNCT01734785 · 2013-02-08 · 1 site observation
COMPLETED
24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary DiseaseNCT01316913 · 2011-03-01 · 1 site observation
COMPLETED
Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular DiseaseNCT01042977 · 2010-03-01 · 1 site observation
COMPLETED
A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With TiotropiumNCT00949975 · 2009-07-01 · 1 site observation
COMPLETED
Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.NCT00496470 · 2007-05-01 · 1 site observation
COMPLETED
Study In People With Type 2 DiabetesNCT00196989 · 2005-09-01 · 1 site observation
COMPLETED
Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mgNCT00242775 · 2005-05-01 · 1 site observation
COMPLETED
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in DiabetesNCT00379769 · 2001-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.